Merck (Germany) Top Insiders

MRK Stock  EUR 140.45  0.15  0.11%   
Merck employs about 63.7 K people. The company is managed by 34 executives with a total tenure of roughly 226 years, averaging almost 6.0 years of service per executive, having 1874.21 employees per reported executive. Examination of Merck's management performance can provide insight into the company performance.
Kenneth Frazier  Chairman
Chairman of the Board, President, Chief Executive Officer
Jennifer Zachary  President
Executive Vice President, General Counsel, Corporate Secretary
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merck Company. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Merck Management Team Effectiveness

The company has return on total asset (ROA) of 0.0656 % which means that it generated a profit of $0.0656 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1422 %, meaning that it generated $0.1422 on every $100 dollars invested by stockholders. Merck's management efficiency ratios could be used to measure how well Merck manages its routine affairs as well as how well it operates its assets and liabilities.

Merck Workforce Comparison

Merck Company is considered to be number one stock in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is now estimated at about 64,039. Merck totals roughly 63,723 in number of employees claiming about 100% of equities under Drug Manufacturers—Specialty & Generic industry.
The company has Profit Margin (PM) of 0.16 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.23 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.23.

Merck Company Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Merck Company Price Series Summation is a cross summation of Merck price series and its benchmark/peer.

Merck Notable Stakeholders

A Merck stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Merck often face trade-offs trying to please all of them. Merck's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Merck's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Kenneth FrazierChairman of the Board, President, Chief Executive OfficerProfile
Jennifer ZacharyExecutive Vice President, General Counsel, Corporate SecretaryProfile
Julie GerberdingExecutive Vice President and Chief Patient Officer, Strategic Communications, Global Public Policy and Population HealthProfile
Rita KarachunSenior Vice President - Finance, Global ControllerProfile
Robert DavisExecutive Vice President, Global Services, Chief Financial OfficerProfile
Michael NallyExecutive Vice President, Chief Marketing OfficerProfile
Roger PerlmutterExecutive Vice President and Presidentident - Merck Research LaboratoriesProfile
Steven MizellExecutive Vice President, Chief Human Resources Officer, Human ResourcesProfile
Sanat ChattopadhyayExecutive Vice President and President - Merck Manufacturing DivisionProfile
Richard DeLucaExecutive Vice President and Presidentident - Merck Animal HealthProfile
Thomas GlocerIndependent DirectorProfile
Christine SeidmanIndependent DirectorProfile
Kathy WardenIndependent DirectorProfile
Paul RothmanIndependent DirectorProfile
Mary CoeIndependent DirectorProfile
Peter WendellIndependent DirectorProfile
Leslie BrunLead Independent DirectorProfile
Inge ThulinIndependent DirectorProfile
Pamela CraigIndependent DirectorProfile
Patricia RussoIndependent DirectorProfile
Thomas CechIndependent DirectorProfile
Matthias HeinzelCEO BoardProfile
Gerhard SchmitzHead AccountingProfile
Constantin FestHead RelationsProfile
Michael FlemingSenior Vice President Chief Ethics and Compliance OfficerProfile
Peter GuenterCEO BoardProfile
Barbara WeilandChief OfficerProfile
Belen MDChair CEOProfile
Marcus KuhnertCFO BoardProfile
Friederike RotschGroup ComplianceProfile
Dirk ToepferChief OfficerProfile
Franklin ClyburnExecutive Vice President Chief Commercial OfficerProfile
Dean LiExecutive Vice President and Presidentident, Merck Research LaboratoriesProfile
Kai BeckmannCEO BoardProfile

About Merck Management Performance

The success or failure of an entity such as Merck Company often depends on how effective the management is. Merck management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Merck management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Merck management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. MERCK Kommanditgesellschaft auf Aktien operates as a subsidiary of E. MERCK KGAA operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 57850 people.

Merck Workforce Analysis

Traditionally, organizations such as Merck use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Merck within its industry.

Merck Manpower Efficiency

Return on Merck Manpower

Revenue Per Employee308.9K
Revenue Per Executive579M
Net Income Per Employee47.9K
Net Income Per Executive89.9M

Complementary Tools for Merck Stock analysis

When running Merck's price analysis, check to measure Merck's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck is operating at the current time. Most of Merck's value examination focuses on studying past and present price action to predict the probability of Merck's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merck's price. Additionally, you may evaluate how the addition of Merck to your portfolios can decrease your overall portfolio volatility.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges